For the past 20 years, Professor Cyrus Cooper has been at the forefront of pioneering research that has changed the way in which we view conditions such as osteoporosis and osteoarthritis; and changed the amount of vitamin D women take during pregnancy. Medically Speaking takes a look at Professor Cooper’s distinguished and influential contribution to the epidemiology field.
What a wonderful relief to look up from the business in hand of sorting through over 12,000 research outputs, 300 impact case studies and 35 environment statements confronting us in sub-panel 1 (Clinical Medicine) of the Research Excellence Framework (REF)
By Professor Cyrus Cooper with Dr Nicholas Fuggle In this blog for Medically Speaking, I thought I would address the important topic of interdisciplinary research. I am joined by Dr Nicholas Fuggle, one of two Faculty Turing Fellows, who has
I still recall the day in 1983, when I was told that my “chosen” research area was osteoporosis. I had completed my senior house officer rotation in medicine between the Royal South Hants Hospital, Lymington and Southampton General the month
In the two decades of clinical research I enjoyed prior to the far-reaching influence of the world-wide web, I recall many fulfilling hours catching up with the literature in the library. This had two enormous benefits which I did not
“It is not the fittest of the species that survives; it is the one most adaptable to change.” So went the famous misquote attributed to one of my heroes Charles Darwin, but actually written by Leon Megginson, Professor of Management
Early December, and National Osteoporosis Society Annual Osteoporosis Conference, saw a busy few days for UK bone clinicians and researchers, not least those of us involved in organising, and contribution to, the meeting.
On election-day, exactly a week ago at the time of writing, I found myself in a hotel room in Geneva, where I was chairing a meeting sponsored by the World Health Organisation and the European Society for the Clinical &
In my last contribution to this Faculty series, I described the work of our various programmes at the MRC Lifecourse Epidemiology Unit. Today, I thought I would give you an insight into the global outreach of our research, by describing